Skip to main content

Contact Dermatitis News

Related terms: Allergic Dermatitis, Dermatitis, Allergic, Dermatitis, Contact

FDA Approves Zoryve for Atopic Dermatitis

THURSDAY, July 11, 2024 – The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric...

Lebrikizumab Tied to Sustained Atopic Dermatitis Treatment Effect

TUESDAY, June 18, 2024 – Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study...

High-Salt Diets Might Raise Eczema Risk

WEDNESDAY, June 5, 2024 – Doctors already warn folks off salt due to its heart risks, but new research suggests sodium isn't helping your skin either. Researchers found that as daily salt intake...

Parental E-Cigarette Use Linked to Increase in Pediatric Atopic Dermatitis

TUESDAY, May 28, 2024 – Parental electronic cigarette use is associated with increased odds of pediatric atopic dermatitis (AD), according to a research letter published online May 22 in JAMA...

Coexistence of Psoriatic Arthritis, Atopic Dermatitis May Offer Treatment Insights

MONDAY, May 13, 2024 – Psoriatic arthritis (PsA) and atopic dermatitis (AD) can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal...

Systemic Antibiotics in First Year of Life Tied to Higher Atopic Dermatitis Risk

WEDNESDAY, May 8, 2024 – Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis (AD) risk in a dose-response fashion, according to a study published...

Stigma Affects Quality of Life in Children With Chronic Skin Conditions

TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...

Atopic Dermatitis Negatively Impacts Mental Health

TUESDAY, April 23, 2024 – Atopic dermatitis (AD) negatively impacts patients’ mental health (MH), especially when a patient has severe AD, according to a study published online March 14 i...

AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis

MONDAY, March 18, 2024 – Lebrikizumab demonstrates improvement in skin clearance and itch relief in patients with skin of color and moderate-to-severe atopic dermatitis, according to a study...

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties

TUESDAY, March 12, 2024 – Pediatric atopic dermatitis (AD) is associated with greater odds of reported difficulties in learning and memory, but this association is driven by children with ...

AAD: Concerns Noted Relating to Use of AI Dermatology Apps

FRIDAY, March 8, 2024 – There are notable concerns relating to the use of currently available artificial intelligence (AI) dermatology mobile applications (apps), according to a study published...

Climatic Hazards Linked to Aggravation of Atopic Dermatitis

WEDNESDAY, Jan. 24, 2024 – Climatic hazards are likely to aggravate atopic dermatitis (AD), with the impact including direct and indirect effects, according to a review published online Jan. 24 in...

Skin Clinic Visits Increased With High Carbon Monoxide Levels Due to Wildfires

WEDNESDAY, Jan. 3, 2024 – An increase in carbon monoxide (CO) levels associated with the Canadian wildfires of 2023 correlated with increased atopic dermatitis (AD), dermatitis, and eczema-related...

Updated Guidelines Released for Management of Atopic Dermatitis

THURSDAY, Dec. 28, 2023 – In updated guidelines issued by the American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology, and published online Dec. 17 in...

Recommendations Developed for Atopic Dermatitis Therapies

THURSDAY, Nov. 16, 2023 – In updated guidelines issued by the American Academy of Dermatology and published online Nov. 7 in the Journal of the American Academy of Dermatology, recommendations are...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dermatitis

Related drug support groups

prednisone, methylprednisolone, clobetasol, fluocinonide, Dupixent, dexamethasone, desonide, halobetasol